| http://www.w3.org/ns/prov#value | - Agent: Novartis Corporate Intellectual Property20090221518 - Compositions and methods for treatment of exudative serous effusion: Compositions and methods are provided for treating accumulation of exudative serous effusions caused by illnesses such as cancer, infection, and pancreatitis.
|
